6533b7d1fe1ef96bd125d8f3
RESEARCH PRODUCT
Targeted synthetic disease-modifying antirheumatic drugs in spondyloarthritis
Clément PratiDaniel Wendlingsubject
medicine.medical_specialtyImmunologyDisease03 medical and health sciencesPsoriatic arthritis0302 clinical medicineHumansImmunology and AllergyMedicineSpondylitis AnkylosingMolecular Targeted TherapyProtein Kinase Inhibitors030203 arthritis & rheumatologyClinical Trials as TopicTofacitinibbusiness.industrymedicine.diseaseDermatologyOncologyNilotinibAntirheumatic Agents030220 oncology & carcinogenesisApremilastbusinessAntirheumatic drugsmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2017-03-01 | Immunotherapy |